Loading...
Transforming Growth Factor-Beta1 in Diabetic Kidney Disease
Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease (ESRD) worldwide. Renin-angiotensin-aldosterone system (RAAS) inhibitors and sodium-glucose co-transporter 2 (SGLT2) inhibitors have shown efficacy in reducing the risk of ESRD. However, patients vary in their response to...
Na minha lista:
| Udgivet i: | Front Cell Dev Biol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7105573/ https://ncbi.nlm.nih.gov/pubmed/32266267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.00187 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|